LIPID MAPS uses cookies to keep the site working, to remember your choices, and — only if you allow it — to understand how the site is used so we can improve it. Choose what you are happy with below. You can change your mind at any time from Manage Cookies in the footer.
Register to help us understand how LIPID MAPS resources are used, measure our impact and improve our services.
Bone marrow-derived macrophages were obtained from tibias and femurs of mice as per protocols PP0000004702 (Harvesting and Plating Thioglycollate Elicited Macrophages for LM Distribution, pdf) and PP0000004602 (ATP / Kdo2-Lipid A treatment, pdf). Cell treatments consisted of a) Control (no treatment); b) Kdo2-Lipid A pretreatment only (4hr pretreamemt, no ATP); c) ATP only (with no Kdo2-Lipid A pretreatment); d) Kdo2-Lipid A pretreatment (4 hrs), followed by addition of ATP at t=0. Lipid/mRNA measurements were taken at t=0 (control only), 15m, 30m, 1h, 2h, 4h, 8h, and 20h (relative to ATP addition at t=0). Measurements were normalized to the average DNA value across all timepoints for each treatment and expressed as pmol analyte/ug DNA.
Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4. Raetz C, Garrett T, Reynolds C, Shaw W, Moore J, Smith JD, Ribeiro A, Murphy R, Ulevitch R, Fearns C, Reichart D, Glass C, Benner C, Subramaniam S, Harkewicz R, Bowers-Gentry R, Buczynski M, Cooper J, Deems R and Dennis E. Journal of Lipid Research 47, 1097-1111 (2006) PMID:16479018 [doi:10.1194/jlr.M600027-JLR200]
This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties.